Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen for prevention of cerebral vasospasm after aneurysmal subarachnoid hemorrhage
ISRCTN14611625Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in subarachnoid hemorrhage (SAH) comparing Ibuprofen plus standard care with Placebo plus standard care (2 arms). Primary endpoints: Ability to recruit participants, Follow-up feasibility and 1 more. Started Jun 2020; status: completed.
02
Drugs
ibuprofen
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on ISRCTN14611625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN14611625.